Cohen, Stanley
Beebe, Jean S.
Chindalore, Vishala
Guan, Shunjie
Hassan-Zahraee, Mina
Saxena, Madhurima
Xi, Li
Hyde, Craig
Koride, Sarita
Levin, Robert
Lubaczewski, Shannon
Salganik, Mikhail
Sloan, Abigail
Stevens, Erin
Peeva, Elena
Vincent, Michael S.
Martin, David A.
Chu, Myron
Article History
Received: 21 December 2023
Accepted: 4 May 2024
First Online: 6 June 2024
Declarations
:
: This study was approved by the Schulman Associates Institutional Review Board, Inc. (reference number IORG000063) and patients provided written informed consent before performing any study-specific activity.
: Not applicable.
: SC is a consultant and investigator for Pfizer Inc. JSB, SK, and MHZ are former employees of Pfizer Inc. VC is an investigator for Pfizer Inc. RL is a consultant for AbbVie, AstraZeneca, and Janssen; investigator for AbbVie, Amgen, AstraZeneca, BMS, Dr. Reddy’s Laboratories, Equillium, GlaxoSmithKline, Idorsia, Janssen, Kangpu, Lilly, Novartis, Pfizer, RemeGen, SunPharm, and Viela Bio; and speaker for AbbVie and GlaxoSmithKline. MV is an employee of and shareholder in Pfizer Inc. SG, LX, MS, CH, SL, MS, AS, ES, EP, DAM, and MC are employees of Pfizer Inc.